SIX Swiss Exchange

Investing in the future of the healthcare industry: Bellevue launches innovative AI Health Fund

Retrieved on: 
Wednesday, January 17, 2024

Investing in the future of the healthcare industry: Bellevue launches innovative AI Health Fund

Key Points: 
  • Investing in the future of the healthcare industry: Bellevue launches innovative AI Health Fund
    Media release of January 15, 2024
    Investing in the future of the healthcare industry: Bellevue launches innovative AI Health Fund
    Generative Artificial Intelligence (GenAI) is bringing about an unprecedented technological transformation.
  • “The investment approach we are taking with the Bellevue AI Health (Lux) Fund that was launched on November 30, 2023 is different.
  • Healthcare will benefit greatly from GenAI,” says Co-Portfolio Manager Stefan Blum, which explains the rationale behind the launch of Bellevue Asset Management's latest healthcare fund.
  • The IT-related risks of implementing AI in healthcare are more calculable than in other industries because healthcare is such a highly regulated market.

Gurit receives gold award for sustainability performance

Retrieved on: 
Saturday, January 13, 2024

Gurit (SIX Swiss Exchange: GURN) has been awarded a gold medal for its sustainability performance from EcoVadis, one of the world’s largest and most trusted sustainability rating agencies.

Key Points: 
  • Gurit (SIX Swiss Exchange: GURN) has been awarded a gold medal for its sustainability performance from EcoVadis, one of the world’s largest and most trusted sustainability rating agencies.
  • This places Gurit in the top 5% of all EcoVadis-rated companies globally.
  • The EcoVadis assessment evaluates 21 sustainability criteria across four core themes: Environment, Labor & Human Rights, Ethics and Sustainable Procurement.
  • Gurit will publish its Sustainability Report 2023 on March 4, 2024.

Implenia becomes partner of the NEST research and innovation platform at Empa and realises the new “Beyond Zero” unit

Retrieved on: 
Saturday, January 13, 2024

More information on the new NEST unit: Empa - NEST - Beyond Zero

Key Points: 
  • More information on the new NEST unit: Empa - NEST - Beyond Zero
    The partnership underlines and expands the Group’s commitment to sustainability.
  • Jens Vollmar, Head Division Buildings at Implenia, about the partnership: “We’re pleased that Implenia is able to work as a partner on this new unit for the great NEST research and innovation platform.
  • The new partnership between Empa and Implenia includes research into innovative building materials, as well as long-term investigations into future-oriented applications on our NEST platform.
  • New partnership between Implenia and NEST platform at Empa: from left to right Reto Largo, Managing Director of NEST at Empa; Dr Jens Vollmar, Head Division Buildings Implenia; Prof. Dr Tanja Zimmermann, Director of Empa; Silvan Merki, Chief Communications Officer Implenia (image: ©NEST).

ABB Ltd: ABB share buybacks - January 4, 2024 - January 10, 2024

Retrieved on: 
Saturday, January 13, 2024

All share purchases above have been carried out on a separate trading line on the SIX Swiss Exchange by a bank, on behalf of ABB.

Key Points: 
  • All share purchases above have been carried out on a separate trading line on the SIX Swiss Exchange by a bank, on behalf of ABB.
  • A full breakdown of the transactions pursuant to article 5.3 of MAR and
    article 2.3 of the Safe Harbour Regulation is attached to this announcement.
  • The bank makes its trading decisions concerning the timing of share repurchases independently of ABB, within some defined parameters.
  • The total number of ABB Ltd shares which have been bought back within the current share buyback program from April 3, 2023, to and including January 10, 2024, is 17,601,000 shares.

Addex to Present at Biotech Showcase™ 2024

Retrieved on: 
Friday, January 5, 2024

For more information or to schedule a one-on-one meeting, please submit a request via the Biotech Showcase partnering platform or by sending an email to [email protected] .

Key Points: 
  • For more information or to schedule a one-on-one meeting, please submit a request via the Biotech Showcase partnering platform or by sending an email to [email protected] .
  • Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available, small molecule drugs known as allosteric modulators for neurological disorders.
  • Addex’s allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention.
  • Indivior PLC has licensed Addex’s GABAB PAM program for the development of drug candidates, with a focus on substance use disorder.

ABB Ltd: ABB share buybacks - December 28, 2023 - January 3, 2024

Retrieved on: 
Thursday, January 4, 2024

All share purchases above have been carried out on a separate trading line on the SIX Swiss Exchange by a bank, on behalf of ABB.

Key Points: 
  • All share purchases above have been carried out on a separate trading line on the SIX Swiss Exchange by a bank, on behalf of ABB.
  • A full breakdown of the transactions pursuant to article 5.3 of MAR and
    article 2.3 of the Safe Harbour Regulation is attached to this announcement.
  • The bank makes its trading decisions concerning the timing of share repurchases independently of ABB, within some defined parameters.
  • The total number of ABB Ltd shares which have been bought back within the current share buyback program from April 3, 2023, to and including January 3, 2024, is 17,257,000 shares.

Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting

Retrieved on: 
Saturday, December 30, 2023

Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting

Key Points: 
  • Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting
    Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting
    Reinach, 21 December 2023 — The shareholders of Evolva Holding SA (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, approved all the proposals put forward by the Board of Directors at today’s extraordinary general meeting (EGM).
  • The shareholders approved with large majorities (see details below) all proposals put forward by the Board of Directors: In particular, the sale by Evolva Holding SA of Evolva AG to Danstar Ferment AG, a Swiss affiliate of Lallemand Inc., was approved which secures the future of Evolva’s operations.
  • We would like to thank the Evolva shareholders for their support in securing the future of Evolva AG’s operations.”
    The convocation of an EGM became necessary after Evolva Holding SA signed, on 20 November 2023, a share purchase agreement with Danstar Ferment AG regarding the sale of all shares in Evolva Holding SA’s wholly owned subsidiary Evolva AG.
  • Agenda item 5 (Delisting of Evolva Holding SA from SIX Swiss Exchange): with 91.10% of the votes represented (votes represented: 3,052,011 votes of the total outstanding shares/votes of 6,827,012).

First trading day for R&S Group on SIX Swiss Exchange

Retrieved on: 
Saturday, December 30, 2023

Following the name change from VT5 Acquisition Company AG to R&S Group Holding AG (R&S Group), the shares of R&S Group Holding AG will be traded for the first time today according to the Swiss Reporting Standard of SIX Swiss Exchange under the ticker symbol RSGN and the ISIN number CH1107979838.

Key Points: 
  • Following the name change from VT5 Acquisition Company AG to R&S Group Holding AG (R&S Group), the shares of R&S Group Holding AG will be traded for the first time today according to the Swiss Reporting Standard of SIX Swiss Exchange under the ticker symbol RSGN and the ISIN number CH1107979838.
  • Following completion of the Initial Business Combination with the first Swiss listed SPAC, VT5 Acquisition Company AG, R&S Group celebrates the start of trading on SIX Swiss Exchange as a public company with the opening bell ceremony at SIX headquarters this morning.
  • Markus Laesser, CEO of R&S Group, said: "Today is a special day for R&S Group and all our stakeholders.
  • As a Swiss engineering leader with high-quality, reliable products and a leading position in its markets, R&S Group fulfills or exceeds VT5's investment principles as defined at the start of VT5.

Helvetia (CH) Swiss Property Fund delivers solid results for 2022/23

Retrieved on: 
Saturday, December 30, 2023

Helvetia (CH) Swiss Property Fundis reporting a solid set of results for 2022/23 against a challenging market backdrop for indirect real estate investments.

Key Points: 
  • Helvetia (CH) Swiss Property Fundis reporting a solid set of results for 2022/23 against a challenging market backdrop for indirect real estate investments.
  • For its fourth financial year, Helvetia (CH) Swiss Property Fund is again able to report an encouraging set of results, in a challenging market environment.
  • The Helvetia (CH) Swiss Property Fund also won three stars in the relative peer comparison.
  • With a market value in excess of one billion Swiss Francs, the Helvetia (CH) Swiss Property Fund is one of the largest non-listed real estate funds in Switzerland.

Ms. Katharina Lichtner nominated for election to the Board of Directors.

Retrieved on: 
Saturday, December 30, 2023

Ms. Katharina Lichtner nominated for election to the Board of Directors.

Key Points: 
  • Ms. Katharina Lichtner nominated for election to the Board of Directors.
  • The Board of Directors of PSP Swiss Property Ltd will propose Mrs. Katharina Lichtner for election as a new member of the Board at the Annual General Meeting of 4 April 2024.
  • With the election of Mrs. Lichtner, the Board of Directors will be strengthened in the areas of corporate finance, ESG as well as real estate market analysis.
  • The Board of Directors of PSP Swiss Property Ltd is very pleased to propose Katharina Lichtner to the Annual General Meeting 2024 for election to the Board of Directors.